About neurodegenerative diseases According to the EU JPND, neurodegenerative diseases refer to conditions that involve the neurons in the brain. These conditions can affect balance, movement, speech, and respiratory and cardiac functions. They can be inherited or be of unknown etiology. Neurodegenerative diseases are incurable and are severely debilitating. They result in progressive degeneration of nerve cells, causing them to die eventually. These diseases cause ataxia and dementia in people, which can have a serious impact on the mental health of patients. Some examples of neurodegenerative diseases are Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, multiple sclerosis, amyotrophic lateral sclerosis, and epilepsy. Huntington’s disease and amyotrophic lateral sclerosis are rare diseases, unlike Alzheimer’s disease and Parkinson’s disease which have a high degree of prevalence. Technavio's analysts forecast the global neurodegenerative diseases market to grow at a CAGR of 4.77 percent over the period 2014-2019. Covered in this report This report covers the present scenario and the growth prospects of the global neurodegenerative diseases market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of neurodegenerative diseases. The market includes data from the sales of various drugs used in the treatment of: • Alzheimer's Disease • Parkinson's Disease • Multiple Sclerosis • Epilepsy • Huntington's Disease • Amyotrophic Lateral Sclerosis The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the global neurodegenerative diseases market. The vendor landscape section includes a market share analysis of the major vendors along with the performances of their product portfolios. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by vendors and the market at large, as well as the key trends that are emerging in the market. In addition, late-stage pipeline molecules developed for the treatment of neurodegenerative diseases are discussed. Technavio's report, Global Neurodegenerative Diseases Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the EMEA, and the APAC; it also covers the global neurodegenerative diseases market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key regions • Americas • APAC • EMEA
• AB Science • Abbvie • Acorda Therapeutics • Actavis • Active Biotech • Adamas Pharmaceuticals • Akorn • Archer Pharmaceuticals • Astellas • Auspex Pharmaceuticals • Bayer • Boehringer Ingelheim • Covis • Desitin Arzneimittel • Eisai • Eli Lilly • Endo International • F. Hoffmann-La Roche • FORUM Pharmaceuticals • GlaxoSmithKline • Glenmark • H. Lundbeck • Ipsen • Janssen Pharmaceuticals • Kyowa Hakko Kirin • Mitsubishi Tanabe • MorphoSys • Newron Pharmaceuticals • Omeros • Opexa • Orion • Otsuka Pharmaceutical • Oxford BioMedica • Palobiofarma • Prana Biotechnology • Raptor Pharmaceutical • Sanofi • Siena Biotech • SOM Biotech • STADA • Takeda Pharmaceutical • TauRx Pharmaceuticals • US WorldMeds • Valeant • Zinfandel Pharmaceuticals Market driver • High unmet medical needs • For a full, detailed list, view our report Market challenge • Generic erosion • For a full, detailed list, view our report Market trend • Reformulation of marketed drugs • For a full, detailed list, view our report
Key Questions Answered in this Report • What will the market size be in 2019 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors?
Our reports have been used by over 10K customers, including:
Aiding care: Emergency funding to counteract the effects of COVID-19 is expected to support industry revenue Abstract Domiciliary Care in the UK Companies operating in the Domiciliary Care industry provide intensive, at-home nursing care to patients. Residential nursing care activities are excluded...
214 pages •
By Asia Market Information & Development Company
• Sep 2020
China’s demand for Central Nervous System Disorder Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports &...
The global narcolepsy market is expected to reach US$ 4,537.9 Mn in 2027 from US$ 2,026.8 Mn in 2018. The market is estimated to grow with a CAGR of 9.5% from 2019-2027. The growth of the narcolepsy market is primarily attributed to the rising prevalence of sleep related neurological disorders, emerging local pharmaceutical and biopharmaceutical...
Summary Centre for Addiction and Mental Health (CAMH) is a healthcare center that offers clinical care and health promotion services.The center offers addictions services, admitting service, child, youth and family service, dual diagnosis service, geriatric mental health service, law and mental health service, mood and...
104 pages •
By Infiniti Research Limited
• May 2018
About CNS therapeutics CNS therapeutics cater to CNS disorders that affect the structure or function of the brain or spinal cord such as Parkinson’s disease, epilepsy, Alzheimer’s disease, anxiety, depression, and bipolar disorders. Technavio’s analysts forecast the Global CNS therapeutics market to grow at a CAGR...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.